Variation in the care of septic shock: The impact of patient and hospital characteristics

Journal of Critical Care

Volumn 27, Issue 4, 2012, Pages 329-336

  Lagu, Tara ^a,b   Rothberg, Michael B ^a,b   Nathanson, Brian H ^c   Pekow, Penelope S ^a,d   Steingrub, Jay S ^a,b   Lindenauer, Peter K ^a,b  

^a BAYSTATE MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c OptiStatim LLC   (United States)

^d UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

Racial disparities; Sepsis; Septic shock; Treatment

Indexed keywords

ACTIVATED PROTEIN C; ALBUMIN; HYDROCORTISONE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ARTIFICIAL VENTILATION; CAUCASIAN; CENTRAL VENOUS PRESSURE; CENTRAL VENOUS PRESSURE MONITORING; CLINICAL ASSESSMENT; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; NEGRO; PATIENT CARE; PATIENT MONITORING; PULMONARY ARTERY CATHETER; SEPTIC SHOCK; TREATMENT INDICATION; UNITED STATES;

AFRICAN AMERICANS; AGE FACTORS; AGED; AGED, 80 AND OVER; CATHETERIZATION, SWAN-GANZ; CENTRAL VENOUS PRESSURE; COMORBIDITY; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HOSPITAL ADMINISTRATION; HOSPITAL MORTALITY; HUMANS; HYDROCORTISONE; LOGISTIC MODELS; MALE; MIDDLE AGED; PROTEIN C; RESPIRATION, ARTIFICIAL; SEX FACTORS; SHOCK, SEPTIC; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 84864133209     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2011.12.003     Document Type: Article

References (36)

1. Zhao Y., Encinosa W. The cost of end-of-life hospitalizations, 2007 2009, Agency for Healthcare Research and Quality, Rockville, MD, Available at:. http://www.hcup-us.ahrq.gov/reports/statbriefs/sb81.pdf.
2. Angus D.C., Linde-Zwirble W.T., Lidicker J., et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29(7):1303-1310.
3. Dellinger R.P., Carlet J.M., Masur H., et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004, 32(3):858-873.
4. Griesdale D.E.G., de Souza R.J., van Dam R.M., et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ 2009, 180(8):821-827.
5. The NICE-SUGAR Study Investigators Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009, 360(13):1283-1297.
6. Annane D., Sébille V., Charpentier C., et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002, 288(7):862-871.
7. Abraham E., Laterre P.F., Garg R., et al. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med 2005, 353(13):1332-1341.
8. Bernard G.R., Margolis B.D., Shanies H.M., et al. Extended evaluation of recombinant human activated protein C United States Trial (ENHANCE US): a single-arm, phase 3B, multicenter study of drotrecogin alfa (activated) in severe sepsis. Chest 2004, 125(6):2206-2216.
9. Bernard G.R., Vincent J.L., Laterre P.F., et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001, 344(10):699-709.
10. Vincent J.L., Bernard G.R., Beale R., et al. Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: further evidence for survival and safety and implications for early treatment. Crit Care Med 2005, 33(10):2266-2277.
11. Annane D., Bellissant E., Bollaert P.E., et al. Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. JAMA 2009, 301(22):2362-2375.
12. Sprung C.L., Annane D., Keh D., et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008, 358(2):111-124.
13. Lindenauer P.K., Rothberg M.B., Nathanson B.H., Pekow P.S., Steingrub J.S. Activated protein C and hospital mortality in septic shock: a propensity-matched analysis. Crit Care Med 2010, 38(4):1101-1107.
14. Ferrer R., Artigas A., Suarez D., et al. Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study. Am J Respir Crit Care Med 2009, 180(9):861-866.
15. Maynard C., Sun H., Lowy E., Sales A.E., Fihn S.D. The use of percutaneous coronary intervention in black and white veterans with acute myocardial infarction. BMC Health Serv Res 2006, 6:107.
16. Petersen L.A., Wright S.M., Peterson E.D., Daley J. Impact of race on cardiac care and outcomes in veterans with acute myocardial infarction. Med Care 2002, 40(1 Suppl):I86-I96.
17. Peterson E.D., Wright S.M., Daley J., Thibault G.E. Racial variation in cardiac procedure use and survival following acute myocardial infarction in the Department of Veterans Affairs. JAMA 1994, 271(15):1175-1180.
18. Schulman K.A., Berlin J.A., Harless W., et al. The effect of race and sex on physicians' recommendations for cardiac catheterization. N Engl J Med 1999, 340(8):618-626.
19. Martin G.S., Mannino D.M., Eaton S., Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003, 348(16):1546-1554.
20. Elixhauser A., Steiner C., Harris D.R., Coffey R.M. Comorbidity measures for use with administrative data. Med Care 1998, 36(1):8-27.
21. Pinheiro J.C., Chao E.C. Efficient Laplacian and adaptive gaussian quadrature algorithms for multilevel generalized linear mixed models. J Comput Graph Stat 2006, 15(1):58-81.
22. Rivers E., Nguyen B., Havstad S., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345(19):1368-1377.
23. Wilkes M.M., Navickis R.J. Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials. Ann Intern Med 2001, 135(3):149-164.
24. Finfer S., Bellomo R., Boyce N., et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004, 350(22):2247-2256.
25. O'Brien J.M., Aberegg S.K., Ali N.A., Diette G.B., Lemeshow S. Results from the national sepsis practice survey: predictions about mortality and morbidity and recommendations for limitation of care orders. Crit Care 2009, 13(3):R96.
26. O'Brien J.M., Aberegg S.K., Ali N.A., Diette G.B., Lemeshow S. Results from the National Sepsis Practice Survey: Use of drotrecogin α (activated) and other therapeutic decisions. J Crit Care 2010, 25(4):658.e7-658.e15.
27. Yu D.T., Black E., Sands K.E., et al. Severe sepsis: variation in resource and therapeutic modality use among academic centers. Crit Care 2003, 7(3):R24-R34.
28. Wennberg J.E., Barnes B.A., Zubkoff M. Professional uncertainty and the problem of supplier-induced demand. Soc Sci Med 1982, 16(7):811-824.
29. Martin G.S., Mannino D.M. Moss M. The effect of age on the development and outcome of adult sepsis. Crit Care Med 2006, 34(1):15-21.
30. Mayr F.B., Yende S., Linde-Zwirble W.T., et al. Infection rate and acute organ dysfunction risk as explanations for racial differences in severe sepsis. JAMA 2010, 303(24):2495-2503.
31. Barnato A.E., Alexander S.L., Linde-Zwirble W.T., Angus D.C. Racial variation in the incidence, care, and outcomes of severe sepsis: analysis of population, patient, and hospital characteristics. Am J Respir Crit Care Med 2008, 177(3):279-284.
32. Mayr F.B., Yende S., D'Angelo G., et al. Do hospitals provide lower quality of care to black patients for pneumonia?. Crit Care Med 2010, 38(3):759-765.
33. Sarrazin M.V., Cannon K.T., Rosenthal G.E., Kaldjian L.C. Racial differences in mortality among veterans hospitalized for exacerbation of chronic obstructive pulmonary disease. J Natl Med Assoc 2009, 101(7):656-662.
34. Kressin N.R., Chang B.H., Whittle J., et al. Racial differences in cardiac catheterization as a function of patients' beliefs. Am J Public Health 2004, 94(12):2091-2097.
35. Barnato A.E., Berhane Z., Weissfeld L.A., et al. Racial variation in end-of-life intensive care use: a race or hospital effect?. Health Serv Res 2006, 41(6):2219-2237.
36. Fisher E.S., Wennberg D.E., Stukel T.A., et al. The implications of regional variations in Medicare spending. Part 2: health outcomes and satisfaction with care. Ann Intern Med 2003, 138(4):288-298.